- Published on November 9, 2021
- In IT Services
Why Did Alphabet Launch A Separate Company For Drug Discovery
Why did Alphabet and DeepMind feel the need for a separate company dedicated to AI-driven drug discovery.
- By Shraddha Goled
One of last week's top stories was the launch of Isomorphic Labs, a company exclusively dedicated to drug discovery, by Alphabet. This newly formed company has Demis Hassabis (also the CEO of DeepMind) as the founder and CEO.
It may be noted that DeepMind achieved a major breakthrough in biology and medical research by devising AlphaFold2. It solved the 50-year-old grand challenge of protein folding by predicting the 3D structure of a protein to atom-level accuracy directly from its amino acid sequence.
Via a brief blog, Hassabis announced the launch of Isomorphic Labs -- presenting a teaser of what the company would be working on and what is that it aspires to achieve. However, not much is known about why Alphabet and DeepMind felt the need for a separate company dedicated to AI-driven drug discovery.
DeepMind & Biomedical Research
"One of the most important applications of AI that I can think of is in the field of biological and medical research, and it is an area I
📣 Want to advertise in AIM? Book here
Shraddha Goled
I am a technology journalist with AIM. I write stories focused on the AI landscape in India and around the world with a special interest in analysing its long term impact on individuals and societies. Reach out to me at shraddha.goled@analyticsindiamag.com.
Related Posts
AI is Redrawing VC Rules as Investors Hedge Bets Against Rival Startups
As AI reshapes markets, VC firms like Sequoia Capital are backing rival startups, raising fresh questions.
Inside IAIRO, India’s ISRO for AI
IAIRO is trying to create an ecosystem in India with funded labs, strong mentors, ambitious peers, and a culture of
For 25 Years, Wikipedia Trained AI. Now it Wants Payback
Wikipedia’s partnerships with Microsoft, Meta, Perplexity, Mistral, and Amazon have ushered it into the AI era.
Global AI Summits, Big Promises, No Rules: Will India’s Be Any Different?
The previous global AI summits have delivered failed promises of self-regulation by Big Tech and voluntary agreements lacking teeth.
How Agentic AI is Redesigning Job Roles for Engineers
EY research shows that 62% of employees in India are already using AI regularly at work.
AI is Forcing the End of Unit Testing. Here’s What It Means for Engineering Talent
The cost of such failures is enormous, forcing teams to rethink how early and how holistically they test.
India’s Big Tech Governance, Unchecked Tech Optimism Alarm Policy Advisors
Policy advisors and civil society groups accuse Big Tech of serving corporate interests with a hawkish AI push.
Why Scrapping 10-min Delivery Doesn’t Give Gig Workers Much Relief
Quick commerce firms are scrapping 10-minute deliveries, but riders still chase incentives and face penalties.
Download the easiest way to
stay informed
stay informed
